Mr. Fred Mermelstein serves as President at Javelin Pharmaceuticals. He is an Angel Investor. He completed his post-doctoral training supported by two grant awards; a National Institutes of Health fellowship and a Howard Hughes Medical Institute fellowship in the Department of Biochemistry at UMDNJ Robert Wood Johnson Medical School.